Pfizer’s COX-2 Parecoxib Is “Not Approvable”
This article was originally published in The Pink Sheet Daily
Executive Summary
Company plans to meet with FDA regarding status of injectable COX-2 agent “as soon as possible.”
You may also be interested in...
Pfizer Aims To Revive Drug Candidates Through Gene Logic Agreement
Gene Logic will screen unapproved compounds for possible new indications with the goal of returning them to clinical development.
Pfizer Aims To Revive Drug Candidates Through Gene Logic Agreement
Gene Logic will screen unapproved compounds for possible new indications with the goal of returning them to clinical development.
Pfizer’s Oporia Is “Not Approvable” For Osteoporosis Prevention
The company says it will consider “various possible courses of action” following FDA’s decision on the selective estrogen receptor modulator.